Congenital disorders of glycosylation : narration of a story through its patents
© 2023. Institut National de la Santé et de la Recherche Médicale (INSERM)..
Congenital disorders of glycosylation are a group of more than 160 rare genetic defects in protein and lipid glycosylation. Since the first clinical report in 1980 of PMM2-CDG, the most common CDG worldwide, research made great strides, but nearly all of them are still missing a cure. CDG diagnosis has been at a rapid pace since the introduction of whole-exome/whole-genome sequencing as a diagnostic tool. Here, we retrace the history of CDG by analyzing all the patents associated with the topic. To this end, we explored the Espacenet database, extracted a list of patents, and then divided them into three major groups: (1) Drugs/therapeutic approaches for CDG, (2) Drug delivery tools for CDG, (3) Diagnostic tools for CDG. Despite the enormous scientific progress experienced in the last 30 years, diagnostic tools, drugs, and biomarkers are still urgently needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Orphanet journal of rare diseases - 18(2023), 1 vom: 29. Aug., Seite 247 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Monticelli, Maria [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 31.08.2023 Date Revised 12.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13023-023-02852-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36142437X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36142437X | ||
| 003 | DE-627 | ||
| 005 | 20240212231908.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13023-023-02852-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1289.xml |
| 035 | |a (DE-627)NLM36142437X | ||
| 035 | |a (NLM)37644541 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Monticelli, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Congenital disorders of glycosylation |b narration of a story through its patents |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2023 | ||
| 500 | |a Date Revised 12.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Institut National de la Santé et de la Recherche Médicale (INSERM). | ||
| 520 | |a Congenital disorders of glycosylation are a group of more than 160 rare genetic defects in protein and lipid glycosylation. Since the first clinical report in 1980 of PMM2-CDG, the most common CDG worldwide, research made great strides, but nearly all of them are still missing a cure. CDG diagnosis has been at a rapid pace since the introduction of whole-exome/whole-genome sequencing as a diagnostic tool. Here, we retrace the history of CDG by analyzing all the patents associated with the topic. To this end, we explored the Espacenet database, extracted a list of patents, and then divided them into three major groups: (1) Drugs/therapeutic approaches for CDG, (2) Drug delivery tools for CDG, (3) Diagnostic tools for CDG. Despite the enormous scientific progress experienced in the last 30 years, diagnostic tools, drugs, and biomarkers are still urgently needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a CDG | |
| 650 | 4 | |a Congenital disorder(s) of glycosylation | |
| 650 | 4 | |a Diagnosis | |
| 650 | 4 | |a Drug Discovery | |
| 650 | 4 | |a Intellectual property | |
| 650 | 4 | |a Patent | |
| 650 | 4 | |a Rare disease | |
| 700 | 1 | |a D'Onofrio, Tania |e verfasserin |4 aut | |
| 700 | 1 | |a Jaeken, Jaak |e verfasserin |4 aut | |
| 700 | 1 | |a Morava, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Andreotti, Giuseppina |e verfasserin |4 aut | |
| 700 | 1 | |a Cubellis, Maria Vittoria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orphanet journal of rare diseases |d 2006 |g 18(2023), 1 vom: 29. Aug., Seite 247 |w (DE-627)NLM163016410 |x 1750-1172 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:1 |g day:29 |g month:08 |g pages:247 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13023-023-02852-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 1 |b 29 |c 08 |h 247 | ||